Explore the latest in clinical and translational research on NAFLD and alcoholic liver diseases at the metabolic, alcohol and toxicity sessions
to be held in Barcelona, 13-17 April 2016. Discover and discuss the new treatment options, disease management and assessment at the joint or early morning workshops. Attend the Grand Rounds and discuss interesting clinical cases.
Keep updated on the importance of the gut-liver-axis at the basic science seminar. And, don’t miss the two symposiums dedicated to public health issues.
Deadline to benefit from early registration fees: 3 February
NASH: Beyond the acronym, certainties and clinical dilemmas
12-14 May 2016
NAFLD as a systemic disease is associated with several pathological conditions from cardiovascular to kidneys and lung diseases. Diagnostic methods will be addressed, including liver histology as well as non-invasive methods.
Defining safe and accurate non-invasive diagnostic methods are an unmet need that is mandatory to resolving and improving the knowledge and management of this entity.
Discover more on the website.
Abstract submission deadline: 12 February 2016
Prof. Michael P. Manns cited by Prof. Juan Rodes
Prof. Christian Trepo cited by Prof. Solko W. Schalm
Discover the faces of the EASL awardees from the past decade and attend General Session 2 on Friday 15 April to find out who will be awarded the 2016 EASL Recognition Awards at this year’s International Liver Congress™.
EASL Hall of Fame.
On 25 January, the European Commission published the evaluation of the 7th Framework Programme, the EU research funding programme for 2007-2013.
The evaluation, conducted by an independent group of high-level experts, analyzes the economic and societal impact of the programme. It has generated several important findings.